# One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

> **NCT00695955** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 669 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Azilsartan medoxomil with or without add-on chlorthalidone
- **DRUG:** Azilsartan medoxomil with or without add-on hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00695955
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 669 (ACTUAL)
- **Last updated:** 2011-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00695955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00695955, "One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00695955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*